Gentiva Reports Fourth Quarter and Fiscal 20...(------ ------- FINANCING ACTIVITIE...)

Date:2/18/2009

------ ------- FINANCING ACTIVITIES: Proceeds from issuance of common stock 11,547 7,882 Windfall tax benefits associated with equity- based compensation 2,227 856 Borrowings under revolving credit facility 24,000 - Debt repayments of acquired company (7,420) - Debt issuance costs (557) - Other debt repayments (83,000) (32,000) Repayment of capital lease obligations (1,147) (1,329) ------ ------ Net cash used in financing activities (54,350) (24,591) ------- ------- Net change in cash and cash equivalents 55,034 3,271 Cash and cash equivalents at beginning of year 14,167 10,896 ------ ------ Cash and cash equivalents at end of year $69,201 $14,167 ======= ======= SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION: Interest paid $21,081 $27,469 Income taxes paid $10,561 $2,389 (in 000's) Supplemental Information 4th Quarter Fiscal Year ------------------------- ----------- ----------- 2008 2007 2008 2007 ---- ---- ---- ---- Segment Information (1) Net revenues Home Health $249,306 $207,494 $942,526 $821,829 CareCentrix - 76,275 23
'/>"/>

SOURCE Gentiva Health Services, Inc. Copyright©2009 PR Newswire. All rights reserved

1 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
Related biology technology :

1. Gentiva Reports Strong Second Quarter led by Home Health Segment
2. Water Street Health Care Partners Completes Agreement With Gentiva Health Services to Acquire Majority Ownership of CareCentrix
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. QMed, Inc. Reports July Medicare SNP Enrollments
5. Phlo Affiliate Reports Expanded Coverage to Oregon Border
6. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
7. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
8. Carrington Reports Second Quarter 2007 Results
9. Avitar Reports Third Quarter Financial Results for Fiscal 2007
10. Response Genetics Reports Second Quarter 2007 Financial Results
11. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results